Nasal swab sampling

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline, Hospices Civils de Lyon

Conditions

AnxietyMood DisordersPost Traumatic Stress DisorderRespiratory Syncytial Virus

Unknown Phase

A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age

CompletedNCT01995175

GlaxoSmithKlineRespiratory Syncytial Virus

Start: 2013-12-12End: 2021-11-03Updated: 2022-11-29

Assisted Animal Therapy: ReAnimal

TerminatedNCT03898843

Hospices Civils de LyonAnxiety, Mood Disorders, Post Traumatic Stress Disorder

Start: 2020-09-18End: 2022-08-24Updated: 2023-05-26

Related Papers

Population Attributable Risk of Wheeze in 2–<6-Year-old Children, Following a Respiratory Syncytial Virus Lower Respiratory Tract Infection in The First 2 Years of Life

The Pediatric Infectious Disease Journal2024-07-015 citations

Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young Children

Journal of the Pediatric Infectious Diseases Society2023-05-0114 citations

Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings

The Journal of Infectious Diseases2022-06-0726 citations

1506. Burden of Respiratory Syncytial Virus (RSV) and Other Lower Respiratory Tract Viral Infections During the First Two Years of Life: a Prospective Study

Open Forum Infectious Diseases2020-10-011 citations

2855. Respiratory Syncytial Virus Neutralizing Antibodies in Cord Blood and Serum from Infants up to 2 Years of Age in a Multinational Prospective Study

Open Forum Infectious Diseases2019-10-01